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Vitamin D Receptor may Participate in the Epithelial-Mesenchymal
Transition of Mouse Podocytes Induced by High Glucose Through Wnt/b-
catenin
Fangxing Zhang, Jia Guo, Congqun Lu, Zhangsuo Liu
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Objective: The expression of vitamin D receptor (VDR) was decreased in dia-
betes patients. Our primary results found that the expression of VDR was
decreased in mouse podocytes induced by high glucose, companied by the
epithelial-mesenchymal transition of podocytes. This experiment was
designed to investigate the mechanism that VDR take part in the epithe-
lial-mesenchymal transition of podocytes.
Methods: Conditionally immortalized mouse podocytes cell line in vitro were
adopted. Podocytes incubated in RPMI-1640 medium with high glucose
(25 mmol/L) or normal glucose (5.6 mmol/L). And normal glucose were
divided into the following three groups according to the experiment’s
design: (1) normal glucose group (5.6 mmol/L); (2) scramble-siRNA group:
normal glucose + 100 pmol/L scramble-siRNA; (3) VDR-siRNA group: normal
glucose + 100 pmol/L VDR-siRNA. After 36 hours, cells were harvested for
protein. The protein expressions were detected by both western-blot and
qRT-PCR. Meanwhile, the change of monolayer barrier function is tested
by using the detection of the albumin influx. The co-localization of VDR
and b-catenin was detected by immunofluorescence.
Results: (1) After high glucose treatment, the protein and gene expressions
of VDR, nephrin and podocin were down-regulated (P < 0.05) while b-cate-
nin, a-SMA and MMP9 was up-regulated (P < 0.05). The albumin flow was
increased. Additionally, more VDR transferred to the nuclear and increased
the co-localization of b-catenin in podocytes under high glucose. (2)
Compared with nomal glucose and scrambled-siRNA group, the the protein
and gene expressions of VDR nephrin and podocin was down-regulated
(P < 0.05), and a-SMA, MMP9 and b-catenin was up-regulated (P < 0.05).
The albumin flow of podocytes was increased (P < 0.05).
Conclusion: Vitamin D receptor may participate in the epithelial-mesen-
chymal transition of mouse podocytes induced by high glucose through
wnt/b-catenin.http://dx.doi.org/10.1016/j.hkjn.2015.08.046
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Tristetraprolin Overexpression Ameliorated Inflammation in db/db Mice
and Mouse Podocytes
Qian Zhang, Jia Guo, Zhangsuo Liu
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Objective: Tristetraprolin (TTP) is a well-characterized, zinc finger-contain-
ing, RNA-binding protein, which plays a role in the regulation of inflamma-
tory factor expression by targeting the 3’ untranslated region (3’UTR). In
the current study, we investigate whether TTP modulates inflammation in
high glucose induced-podocytes and in db/db mice kidneys.
Methods: Differentiated mouse podocytes were treated by high glucose, and
TTP expression and inflammatory factors was measured by quantitative real-
time PCR or ELISA. TTP siRNA or lentiviral vectors containing TTP sequences
were transfected into podocytes to down-regulate or up-regulate TTP
expression. Db/db mice were used as the diabetic model in in vivo experi-
ment. At the age of 10 weeks, db/db mice were injected via tail vein with
lentiviral vectors containing TTP sequences. At the age of 14 weeks, the
lentivirus injection was repeated. Mices were sacrificed at the the age of
22 weeks. Inflammatory factors (IL-6, IL-18, TNF-a), fibrosis markers (fibro-
nectin, MMP-9) and podocyte markers (nephrin, podocin) in mice kidneys
were examined by western blot and immunohistochemistry. Urine albumin
to creatinine ratio and serum creatinine was also detected.
Results: TTP was down-regulated while IL-6, IL-18, TNF-a were up-regulated
in high glucose-induced mouse podocytes. Silencing TTP by siRNA induced in-
flammatory factor expression. Overexpression of TTP reduced the expression
of inflammatory factors in high glucose-induced podocytes. In vivo, TTP
expression was significantly decreased in db/db mice kidneys compared
with db/m mice. Through the lentivirus injection, TTP expression was up-
regulated in the kidneys of db/db mice at the 22nd week. Overexpression
of TTP caused reduced expression of inflammatory factors (IL-6, IL-18,
TNF-a) and fibrosis markers (fibronectin, MMP-9), as well as restored expres-
sion of podocyte markers (nephrin, podocin) in the diabetic kidneys,indicating a protective role in db/db mice. Urine albumin to creatinine ratio
was also decreased in db/db mice overexpressing TTP.
Conclusion: TTP is involved in the regulation of renal inflammation in db/db
mice.http://dx.doi.org/10.1016/j.hkjn.2015.08.047
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Associated with Proteinuria and Diabetic Nephropathy
Yang Yang, Guo Jia, Zhangsuo Liu
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Objective: Vitamin D receptor (VDR) is a member of the nuclear receptor su-
perfamily, and there has no report about the expression of Vitamin D and its
receptor in patients with diabetes associated with proteinuria and diabetic
nephropathy. So, this study aimed texplore the role of VDR in diabetic
nephropathy.
Methods: (1) 65 patients who had been diagnosed with T2DM (with or
without albuminuria) were enrolled in this study and 25 healthy control sub-
jects were enrolled (NC group). The patients were classified according to the
ratio of urinary excretion of albumin/creatinine (ACR). Diabetic patients
without proteinuria (DM group, ACR: less than 30 mg/g, nZ 25), with micro-
albuminuria (DN1 group, ACR: 30 to 300 mg/g, n Z 24) and clinical protein-
uria (DN2 group, ACR: more than 300 mg/g, n Z 18). 25 diabetic
nephropathy patients who were diagnosed by renal biopsy (DN3 group). (2)
The expressions of VD and VDR were investigated by ELISA, qRT-PCR, and
immunohistochemical staining.
Results: Plasma VD and VDR levels were significantly lower in DN2 and DN3
groups as compared with NC group (plasma VD 0.78  0.24 and 0.88  0.29
vs. 2.32  1.33 ng/ml, P < 0.05, VDR 157.52  98.36 and 164.20  64.50
vs. 325.33  194.68 ng/ml, P < 0.05). Urinary VD and VDR levels were signif-
icantly elevated in DN2 and DN3 groups as compared with NC group (urinary
VD 1.34  0.58 and 1.42  0.44 vs. 1.18  0.65 ng/ml, P < 0.05, VDR
83.60  31.78 and 88.40  28.10 vs. 60.93  12.03 ng/ml, P < 0.05).
Conclusion: These results verify that VDR may play a role of renal protection
in diabetic nephropathy.http://dx.doi.org/10.1016/j.hkjn.2015.08.048
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Sirt1 Might Modulate the Expressions of TTP and Inflammatory Factors
Through MAPK P38 in High Glucose-induced Mouse Podocytes
Minglei Lu, Jia Guo, Zhangsuo Liu
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Objective: Sirt1 (silent information regulator 1), a type III protein deacety-
lase, is considered as a novel anti-aging protein involved in regulation of
inflammation in diabetic nephropathy. The objective of this study was to
observe the expressions of sirt1, TTP and inflammatory factors in high
glucose-induced mouse podocytes, and initially explore its regulatory
mechanism.
Methods: (1) Differentiated podocytes were divided into: the normal glucose
group (NG: glucose 5.6 mM), the HG groups (HG: 25 mM of glucose), and the
osmotic control group (NG+M: glucose 5.6 mM and mannitol 25.6 mM). Sirt1,
TTP, IL-6 and IL-18 were assessed using quantitative RT-PCR, western blot
and immunofluorescence. (2) In normal glucoseconditon, MAPK P38, TTP,
IL-6 and IL-18 were assessed using quantitative RT-PCR, western blot by us-
ing a sirt1 small-interfering RNA (siRNA) transfection.
Results: (1) Sirt1mainly located in the nucleus ofmouse podocytes in NG group.
In comparisonwithNGandNG+M,HGstatistically significantlydecreased theex-
pressions of sirt1and TTP, and increased the IL-6 and IL-18 expressions. (2) Sig-
nificant decreased expressions of TTP and MAPK P38 was observed in NG sirt1
siRNA transfection, and the higher IL-6 and IL-18 expressions.
Conclusion: Sirt1 might modulate the expressions of TTP through MAPK P38
in mouse podocytes.http://dx.doi.org/10.1016/j.hkjn.2015.08.049
